相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system
C. Steininger
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins
Elizabeth A. Reap et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12
MA Jacobson et al.
VACCINE (2006)
A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines
TC Heineman et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
I. Poloxamer- formulated plasmid DNA-based human cytomegalovirus vaccine: Evaluation of plasmid DNA biodistribution/persistence and integration
A Vilalta et al.
HUMAN GENE THERAPY (2005)
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
AW Sylwester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Is the cytomegalovirus serologic status always accurate?: A comparative analysis of humoral and cellular immunity
M Sester et al.
TRANSPLANTATION (2003)
Primary immune responses to human CMV:: a critical role for IFN-γ-producing CD4+ T cells in protection against CMV disease
LE Gamadia et al.
BLOOD (2003)
Avidity maturation following immunization with two human cytomegalovirus (CMV) vaccines: A live attenuated vaccine (Towne) and a recombinant glycoprotein vaccine (gB/MF59)
BC Marshall et al.
VIRAL IMMUNOLOGY (2003)
Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals
F Kern et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study
C Junghanss et al.
BLOOD (2002)
Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults
DI Bernstein et al.
JOURNAL OF INFECTIOUS DISEASES (2002)